SCHEMBL4224153

SCHEMBL4224153

CC1CN1C(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21483385 0.76
SCHEMBL16945613 0.76
SCHEMBL4842013 0.73 TSHR (0.37)
SCHEMBL20402406 0.72
SCHEMBL16945615 0.72
SCHEMBL16945636 0.72
SCHEMBL6221976 0.71 HPGD (0.47)
SCHEMBL8362604 0.71
SCHEMBL24952665 0.69
SCHEMBL3594955 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240050578-A1 BI-FUNCTIONAL MOLECULES TO DEGRADE CIRCULATING PROTEINS UNIV YALE (US) 2024-02-15 US claimed
US-11767301-B2 Bi-functional molecules to degrade circulating proteins YALE UNIVERSITY (US) 2023-09-26 US claimed
US-20230233689-A1 Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins UNIV YALE (US) 2023-07-27 US claimed
US-20230159611-A1 SMALL MOLECULE ADAPTER REGULATED, TARGET SPECIFIC CHIMERIC ANTIGEN RECEPTOR BEARING T CELLS (SMART CARS) YALE UNIVERSITY 2023-05-25 US claimed
US-20230097887-A1 Bi-functional Molecules to Degrade Circulating Proteins YALE UNIVERSITY 2023-03-30 US claimed
US-20230083388-A1 Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins UNIV YALE (US) 2023-03-16 US claimed
US-20210145974-A1 Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins YALE UNIVERSITY 2021-05-20 US claimed
US-20210139436-A1 Bi-functional Molecules to Degrade Circulating Proteins YALE UNIVERSITY 2021-05-13 US claimed
US-10961527-B2 Reprogramming urokinase into an antibody-recruiting anticancer agent YALE UNIVERSITY (US) 2021-03-30 US claimed
EP-3773727-A1 BIFUNCTIONAL SMALL MOLECULES TO TARGET THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS Yale University (US) 2021-02-17 EP claimed
WO-2017053776-A1 THE TOTAL SYNTHESIS OF GLUCOSEPANE AND COMPOUNDS OBTAINED THEREFROM YALE UNIVERSITY (US) 2017-03-30 WO claimed
WO-2017023994-A1 SMALL MOLECULE BASED ANTIBODY-RECRUITING COMPOUNDS FOR CANCER TREATMENT YALE UNIVERSITY (US) 2017-02-09 WO claimed
US-9556167-B2 TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs) YALE UNIVERSITY (US) 2017-01-31 US claimed
US-20150110742-A1 TLR-AGONIST-CONJUGATED ANTIBODY RECRUITING MOLECULES (TLR-ARMS) YALE UNIVERSITY (US) 2015-04-23 US claimed
WO-2013166110-A1 TLR-AGONIST-CONJUGATED ANTIBODY RECRUITING MOLECULES (TLR_ARMS) YALE UNIVERSITY (US) 2013-11-07 WO claimed
EP-1408986-A4 PROTEOMIMETIC COMPOUNDS AND METHODS UNIV YALE (US) 2006-01-11 EP claimed
US-20050215563-A1 Proteomimetic compounds and methods YALE UNIVERSITY 2005-09-29 US claimed
EP-1408986-A2 PROTEOMIMETIC COMPOUNDS AND METHODS YALE UNIVERSITY (US) 2004-04-21 EP claimed
US-20030008882-A1 Proteomimetic compounds and methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-01-09 US claimed
WO-2002089738-A2 PROTEOMIMETIC COMPOUNDS AND METHODS YALE UNIVERSITY (US) 2002-11-14 WO claimed